ResearcherUniversidade de São PauloActive in the last 2 years
Guilherme Naccache Namur
Matched on ORCID iD 0000-0001-8102-6568; OpenAlex author ID A5069226563. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: 2 papers · 2025: none · 2026: 1 paper
Papers 5
- Detection of mutated KRAS, TP53, CDKN2A, and SMAD4 in tumor cell-free DNA of Brazilian pancreatic adenocarcinoma patients using next-generation sequencing. Co-author DOI 10.1038/s41598-026-42403-4↗
- IS THERE A ROLE FOR BILIODIGESTIVE BYPASS SURGERY IN TREATING CHOLESTASIS IN ADVANCED PANCREATIC CANCER? Last author DOI 10.1590/0102-6720202400030e1823↗
- Concomitant or antecedent intraductal papillary mucinous neoplasm is not a prognostic factor in resected pancreatic cancer. Co-author DOI 10.21037/jgo-24-157↗
- Circulating Cell-Free Nucleic Acids as Biomarkers for Diagnosis and Prognosis of Pancreatic Cancer. Co-author DOI 10.3390/biomedicines11041069↗
- Evaluation of microvessel density and p53 expression in pancreatic adenocarcinoma. Co-author DOI 10.6061/clinics/2016(06)05↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Anelis Maria Marin · 2 shared papers, 2023–2026 · strength 0.49
- Mateus Nóbrega Aoki · 2 shared papers, 2023–2026 · strength 0.49
- Francisco Tustumi · 2 shared papers, 2024 · strength 0.40
- Ricardo Jureidini · 2 shared papers, 2016–2024 · strength 0.27
- Federico Canzian · 1 shared paper, 2026 · strength 0.27
- Lucas Cata Preta Stolzemburg · 1 shared paper, 2024 · strength 0.22
- Mitesh J. Borad · 1 shared paper, 2024 · strength 0.18
- Diogo Diniz Gomes Bugano · 1 shared paper, 2024 · strength 0.18
- Fernando Moura · 1 shared paper, 2024 · strength 0.18
- Pedro Luiz Serrano Usón · 1 shared paper, 2024 · strength 0.18
- Ivan Cecconello · 1 shared paper, 2016 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.